Parathyroid adenoma: detailed overview

1) Epidemiology and importance

• PHPT is a common endocrine disorder and a major cause of hypercalcemia.
• Underlying lesion frequencies in PHPT:
  • Adenoma: 85 to 95%
  • Hyperplasia: 5 to 10%
  • Carcinoma: around 1%
• Typical patient profile: adults, often over 50, female predominance.

2) Pathophysiology

• Increased bone resorption
• Increased distal tubular calcium reabsorption
• Increased phosphaturia
• Increased 1,25-dihydroxyvitamin D production

• High calcium
• Low/low-normal phosphate
• Elevated or inappropriately normal PTH

3) Molecular biology and genetics

• Cyclin D1 (CCND1) dysregulation (gene rearrangement/overexpression)
• MEN1 mutations in a subset of sporadic tumors
• CDC73 alterations are more linked to carcinoma/atypical neoplasms, but can occasionally occur in adenoma contexts

• MEN1, MEN2A, MEN4
• Hyperparathyroidism-jaw tumor syndrome (CDC73 related)

4) Pathology (gross and microscopic)

• Solitary, well-circumscribed, encapsulated tan to reddish-brown nodule
• Usually about 0.5 to 5 g
• Remaining glands often normal or shrunken (feedback suppression)

• Predominantly chief cells in sheets/nests
• Reduced stromal fat compared with normal gland
• Can show endocrine atypia (nuclear pleomorphism) without malignancy
• Mitotic figures uncommon

Histology image example

• Panel A shows adenoma tissue demarcated from residual fat-containing non-neoplastic parathyroid.
• Panel B shows monotonous chief-cell proliferation at higher power.

5) Clinical presentation

• “Bones”: bone pain, osteoporosis, osteitis fibrosa cystica, brown tumors
• “Stones”: nephrolithiasis, nephrocalcinosis
• “Groans”: GI symptoms (constipation, nausea, abdominal complaints, pancreatitis in some cases)
• “Psychic moans”: fatigue, mood/cognitive symptoms, depression, lethargy

6) Diagnosis

• Serum total and/or ionized calcium
• Intact PTH
• Phosphate, creatinine/eGFR
• 25-hydroxyvitamin D
• 24-hour urinary calcium (important to distinguish from familial hypocalciuric hypercalcemia)
• Bone mineral density (DXA), renal imaging in selected cases

• Hypercalcemic PHPT (most common)
• Normohormonal PHPT (high Ca with unsuppressed PTH)
• Normocalcemic PHPT (selected cases, after secondary causes excluded)

7) Imaging/localization modalities

• High-resolution neck ultrasound
• Tc-99m sestamibi scintigraphy (often with SPECT/CT)
• 4D-CT (useful in discordant/negative first-line imaging, ectopic/small lesions)
• MRI or PET/CT for difficult/reoperative cases

8) Treatment

• Focused/minimally invasive parathyroidectomy when localization is concordant
• Bilateral neck exploration when localization unclear, concern for multigland disease, or reoperative complexity

• Avoid unnecessary calcium restriction
• Replete vitamin D as appropriate
• Antiresorptives for bone protection in selected patients
• Calcimimetic therapy (cinacalcet) for calcium lowering in selected cases

9) Complications and postoperative issues

• Untreated disease: fracture risk, kidney stones, renal calcification, chronic hypercalcemia effects
• Post-op:
  • Hypocalcemia (including hungry bone syndrome in severe bone disease)
  • Persistent/recurrent hyperparathyroidism if multigland disease missed or ectopic tissue remains
• Intraoperative PTH monitoring is often used to confirm adequate excision (rapid PTH half-life supports this strategy)

10) Differential diagnosis

• Primary multigland hyperplasia
• Parathyroid carcinoma
• Familial hypocalciuric hypercalcemia
• Secondary/tertiary hyperparathyroidism (especially CKD context)
• Non-PTH hypercalcemia (malignancy, vitamin D excess, others)

Recent evidence check (last 2 years)

• PMID: 38739762 (skeletal effects of parathyroidectomy in PHPT)
• PMID: 41721481 (anesthesia approach in minimally invasive parathyroidectomy)
• PMID: 37929814 (4D-CT in discordant adenoma scans)

• surgery improves bone outcomes
• 4D-CT has an important role when first-line localization is discordant

Textbook sources

• Robbins, Cotran & Kumar Pathologic Basis of Disease, endocrine/parathyroid sections, histology and clinical features (pp. around 1010-1013 in extracted block context)
• Robbins & Kumar Basic Pathology, hyperparathyroidism morphology/clinical sections (pp. around 741-743 in extracted block context)
• Sabiston Textbook of Surgery, parathyroid surgery/localization/management chapter (pp. around 1541-1545 in extracted block context)

1. a concise exam-oriented table (adenoma vs hyperplasia vs carcinoma), or
2. a practical clinical algorithm for evaluating hypercalcemia and confirming parathyroid adenoma.

1) Story mnemonic: “The One Rebel Gland”

• Bones: walls are mined for calcium → osteopenia/osteoporosis, bone pain, brown tumors in severe disease
• Kidneys: calcium stones clog river channels → nephrolithiasis/nephrocalcinosis
• Belly: villagers complain of constipation, nausea, abdominal discomfort
• Brain/Mood: fatigue, low mood, cognitive fog

Villain signature (lab pattern)

• Calcium: high
• PTH: high or “inappropriately normal”
• Phosphate: often low
• Urinary calcium: usually not low (helps separate from FHH)

2) Creative comparison table: “The 3 suspects in hyperparathyroidism court”

3) Creative diagnostic algorithm: “Calcium Detective Map”

Step A: Confirm the crime

1. High calcium found
2. Check intact PTH
   • If PTH high or not suppressed → PTH-dependent hypercalcemia (suspect PHPT)

Step B: Identify impostors

1. Check 24-hour urinary calcium (or calcium/creatinine clearance ratio)
   • Low urinary calcium suggests FHH rather than adenoma

Step C: Check damage report

1. Bone: DXA ± fracture risk
2. Kidney: creatinine/eGFR, stone screen (US/CT as needed)

Step D: Locate the rebel (only after biochemical diagnosis)

1. Ultrasound ± sestamibi/SPECT
2. If discordant or negative, consider 4D-CT
3. Difficult/reoperative cases: MRI/PET options

Step E: Restore order

1. Parathyroidectomy when indicated/suitable
2. If not surgical candidate: medical monitoring, bone protection, calcium/vitamin D optimization, selective cinacalcet use

4) Ultra-short viva style memory hooks

• “Single gland, single culprit” = adenoma
• “PTH not suppressed despite high calcium” = primary hyperparathyroidism pattern
• “Diagnosis is biochemical, imaging is localization”
• “Adenoma first, hyperplasia second, carcinoma rare”

1. a one-page colorful revision sheet, or
2. 15 rapid-fire MCQs with explanations.

One-page revision sheet: Parathyroid Adenoma

Snapshot

• Definition: Benign neoplasm of parathyroid tissue causing autonomous PTH secretion
• Most common cause of PHPT: 85 to 95%
• Typical pattern: Single-gland disease

Core physiology in one line

Biochemical signature

• Serum calcium: high
• PTH: high or inappropriately normal
• Serum phosphate: often low
• Urinary calcium: usually normal/high (not low like many FHH cases)

Classic clinical picture

• Bones: osteopenia/osteoporosis, bone pain, severe cases with osteitis fibrosa cystica/brown tumors
• Stones: nephrolithiasis, nephrocalcinosis
• GI: constipation, nausea, abdominal discomfort
• Neuropsych: fatigue, mood/cognitive symptoms

Pathology pearls

• Usually solitary, well-circumscribed, soft tan nodule
• Chief-cell predominant, reduced stromal fat
• Endocrine atypia can occur and is not equal to carcinoma
• Other glands are often suppressed/shrunken

Adenoma vs hyperplasia vs carcinoma

• Adenoma: single gland, most common
• Hyperplasia: usually multigland
• Carcinoma: rare, diagnosis hinges on invasion/metastasis

Diagnostic algorithm (exam-safe)

1. Confirm hypercalcemia
2. Measure intact PTH
3. If PTH-dependent pattern, exclude FHH (24-hour urinary calcium or Ca/Cr clearance ratio)
4. Assess end-organ effects: bone density, renal status/stones
5. Localize only after biochemical diagnosis: US + sestamibi/SPECT, then 4D-CT if needed

Management

• Definitive: parathyroidectomy
• Focused minimally invasive surgery when localization is concordant
• If non-surgical: monitoring, bone-directed therapy as needed, vitamin D optimization, selected cinacalcet use

High-yield pitfalls

• Imaging does not diagnose PHPT; labs do
• “Normal PTH” is abnormal if calcium is high
• Do not miss FHH before surgery decisions

15 rapid-fire MCQs (with answers)

1) Most common cause of primary hyperparathyroidism?

2) Typical gland involvement in parathyroid adenoma?

3) Typical biochemical pattern in adenoma-related PHPT:

4) Which is usually lower in PHPT?

5) Before localizing scans, the most important first step is:

6) Which test helps distinguish PHPT from FHH?

7) Histology most commonly seen in adenoma:

8) A key criterion for parathyroid carcinoma diagnosis:

9) Classic symptom cluster includes all except:

10) Definitive treatment for fit patient with symptomatic adenoma:

11) Which statement is correct?

12) Common genetic alteration in sporadic adenomas:

13) In many modern cases, PHPT is first found by:

14) Hyperplasia differs from adenoma because hyperplasia is usually:

15) True regarding PTH in hypercalcemia due to adenoma: